BRANDY REINTS: Open Payments
NPI 1306406681 · PARKERSBURG, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 11 payments from 6 companies in 2025. Trend: 2023 $43 · 2024 $144 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $68 |
| Lilly USA, LLC | 3 | $52 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| Amgen Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $13 |
Products named: Wegovy, VOQUEZNA, MOUNJARO, Ozempic, ZEPBOUND, OTEZLA, REXULTI, VRAYLAR.
Industry payments across IA — which companies pay providers there.
